Bedford Labs Issues Recall for Cytarabine
Bedford Laboratories has issued a recall for three lots of the injectable cancer drug Cytarabine . The company issued the recall because an investigation has revealed that the manufacturing area had a “lack of sterility assurance.” Cytarabine is approved to be used with other cancer drugs for non-lymphatic leukemia of adults and children. It is used in emergency rooms, healthcare facilities,